Lovastatin Therapy in Hypercholesterolemia: Effect on Fibrinogen, Hemorrheologic Parameters, Platelet Activity, and Red Blood Cell Morphology

Yitzhak Beigel*, Jacob Fuchs, Moshe Snir, Pnina Green, Yoav Lurie, Menachem Djaldetti

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The effect of lovastatin therapy on blood rheology was investigated in 26 hypercholesterolemia patients. Treatment with lovastatin was associated with a significant improvement in whole blood filtration time and a tendency toward normalization in red blood cell morphology. A significant increase was observed in fibrinogen level, in ADP‐induced platelet aggregation, in the percentage of “big” platelets, and in platelet count. The viscosity of whole blood and plasma and the percentage of aggregated platelets did not change significantly. The cause for these hemorrheologic changes and their role in influencing the coronary risk of lovastatin‐treated hypercholesterolemia patients should be further investigated. 1991 American College of Clinical Pharmacology

Original languageEnglish
Pages (from-to)512-517
Number of pages6
JournalJournal of Clinical Pharmacology
Volume31
Issue number6
DOIs
StatePublished - Jun 1991

Fingerprint

Dive into the research topics of 'Lovastatin Therapy in Hypercholesterolemia: Effect on Fibrinogen, Hemorrheologic Parameters, Platelet Activity, and Red Blood Cell Morphology'. Together they form a unique fingerprint.

Cite this